{"product_id":"dsip-10mg-research-compound-copy","title":"Celebrolysin 60mg Research Compound","description":"\u003cp\u003e\u003cstrong\u003eCelebrolysin (Cerebrolysin)\u003c\/strong\u003e is not a single peptide — it’s a \u003cstrong\u003ecomplex mixture of low‑molecular‑weight neuropeptides\u003c\/strong\u003e derived from \u003cstrong\u003eporcine brain proteins\u003c\/strong\u003e, designed to mimic natural neurotrophic factors like \u003cstrong\u003eBDNF, NGF, GDNF, and CNTF\u003c\/strong\u003e. It’s used clinically in parts of Europe and Asia for \u003cstrong\u003estroke recovery, dementia, traumatic brain injury\u003c\/strong\u003e, and experimentally as a \u003cstrong\u003ehigh‑end nootropic\u003c\/strong\u003e\u003cstrong\u003e\u003c\/strong\u003e\u003c\/p\u003e\n\u003ch2\u003eResearch being Documented (Clinical + Experimental)\u003c\/h2\u003e\n\u003ch3\u003e1. \u003cstrong\u003eNeuroprotection\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eProtects neurons from ischemic damage and oxidative stress. Supported in TBI and neurodegenerative models. \u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 class=\"text-lg-strong pb-1 [\u0026amp;:not(:first-child)]:pt-3.5\"\u003e2. \u003cstrong\u003eNeuroplasticity \u0026amp; Synaptic Growth\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eActivates PI3K\/Akt, MAPK, and CREB pathways → improved learning and memory. \u003c\/span\u003e\u003c\/p\u003e\n\u003ch3 class=\"text-lg-strong pb-1 [\u0026amp;:not(:first-child)]:pt-3.5\"\u003e3. \u003cstrong\u003eCognitive Enhancement\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eMost consistent improvements:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul role=\"list\"\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eMemory formation\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eProcessing speed\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eVerbal fluency\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eExecutive function Effects often appear after \u003cstrong\u003e1–4 weeks\u003c\/strong\u003e of a treatment cycle. \u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch3 class=\"text-lg-strong pb-1 [\u0026amp;:not(:first-child)]:pt-3.5\"\u003e4. \u003cstrong\u003ePotential Clinical Uses\u003c\/strong\u003e\n\u003c\/h3\u003e\n\u003cp\u003e\u003cspan\u003eEvidence ranges from promising to inconclusive:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul role=\"list\"\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eVascular dementia\u003c\/strong\u003e → modest improvement \u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"ps-2\"\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eAlzheimer’s disease\u003c\/strong\u003e → preliminary benefit, needs better trials \u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"ps-2\"\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eTraumatic brain injury\u003c\/strong\u003e → multiple meta‑analyses show functional improvement \u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli class=\"ps-2\"\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eStroke\u003c\/strong\u003e → recent Cochrane review: \u003cstrong\u003eno clear benefit\u003c\/strong\u003e and possible increased adverse events \u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"relative pb-6 w-full after:border-b after:border-stroke-300 after:w-full after:absolute after:mt-3\"\u003e\u003cbr\u003e\u003c\/div\u003e\n\u003ch2\u003e⚠️ Safety \u0026amp; Side Effects\u003c\/h2\u003e\n\u003cp\u003e\u003cspan\u003eCelebrolysin is generally well‑tolerated but can cause:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul role=\"list\"\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eHeadache\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eDizziness\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eNausea\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eSweating\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eInjection‑site irritation \u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan\u003e\u003cstrong\u003eNot recommended\u003c\/strong\u003e for:\u003c\/span\u003e\u003c\/p\u003e\n\u003cul role=\"list\"\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eEpilepsy\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eSevere kidney disease\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003e\u003cspan\u003eHypersensitivity to porcine proteins\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eResearch Disclaimer:\u003c\/strong\u003e\u003cspan\u003e \u003c\/span\u003eBLVE products are for laboratory and scientific research only and are not intended for human consumption, veterinary use, clinical application, or therapeutic treatment. All research must be conducted by qualified professionals in appropriate laboratory environments.\u003c\/p\u003e","brand":"BLVE","offers":[{"title":"Default Title","offer_id":52593992368440,"sku":null,"price":65.0,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1002\/7787\/9096\/files\/th_4aca9760-7bb8-4459-bc11-1e86e5937183.webp?v=1782925773","url":"https:\/\/blve.life\/products\/dsip-10mg-research-compound-copy","provider":"BLVE","version":"1.0","type":"link"}